NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Director John W Smither sold $41K of NewAmsterdam Pharma Company N.V.
Sold$40,512
$25.32Price
1,600Shares
−15%Stake
What NAMS did after the filing
- The stock from Thu, Sep 10 open, $22.44
- −3.8%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Oct 22 close.
Traded Fri, Sep 4. Filed Wed, Sep 9, 4:30 PM ET, after the close. Returns use the Sep 10 open and the Oct 22 close. Not investment advice.